Dr. Subhash K. Banerjee

As a board-certified interventional cardiologist, Dr. Banerjee is internationally recognized for his expertise in minimally invasive treatments of coronary artery disease, peripheral artery disease and transcatheter aortic valve replacement. He is currently serving as the Paul J. Thomas Endowed Chair in Cardiology and chief of cardiovascular research and innovation for Baylor Scott & White Heart and Vascular Services-Dallas. Dr. Banerjee is the editor-in-chief of the American Journal of Cardiology, one of the premier cardiology journals in the world. He also serves as one of the founding directors of the Cardiovascular Innovations Foundation. He has led many landmark clinical trials, published over 450 peer-reviewed manuscripts, and is an invited faculty at national and international cardiovascular conferences.

Dr. Banerjee is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Atherectomy, and Angioplasty.

Dr. Banerjee is board certified in Cardiovascular Disease- American Board Of Internal Medicine, Cardiovascular Disease- American Board Of Internal Medicine - Cardiovascular Disease, Interventional Cardiology- American Board Of Internal Med/Interventional Cardiology, Interventional Cardiology- American Board Of Internal Medicine - Interventional Cardiology, Interventional Cardiology- American Board Of Internal Medicine, Interventional Cardiology- American Board Of Internal Medicine/Interventional Cardiology, Cardiovascular Disease- American Board Of Internal Medicine/Cardiovascular Disease, and Cardiovascular Disease- American Board Of Internal Med/Cardiovascular Disease. He is actively involved in clinical research, co-authoring 514 peer reviewed articles and participating in 6 clinical trials. Dr. Banerjee is currently accepting new patients.